Fig. 3From: Clinical research of intraperitoneal implantation of sustained-release 5-fluorouracil in advanced colorectal cancerKaplan-Meier survival analysis (group 1, black line; group 2, red line). The colonic cancer group-specific 5-year overall survival (OS) rates were 57.5 % in group 1 and 37.0 % in group 2 (P = 0.04, significant difference). These differences were statistically significantBack to article page